1. Home
  2. SVRN vs HSCS Comparison

SVRN vs HSCS Comparison

Compare SVRN & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRN
  • HSCS
  • Stock Information
  • Founded
  • SVRN 2021
  • HSCS 2007
  • Country
  • SVRN Greece
  • HSCS United States
  • Employees
  • SVRN N/A
  • HSCS N/A
  • Industry
  • SVRN Marine Transportation
  • HSCS Medical Specialities
  • Sector
  • SVRN Consumer Discretionary
  • HSCS Health Care
  • Exchange
  • SVRN Nasdaq
  • HSCS Nasdaq
  • Market Cap
  • SVRN 9.1M
  • HSCS 9.9M
  • IPO Year
  • SVRN N/A
  • HSCS 2022
  • Fundamental
  • Price
  • SVRN $1.41
  • HSCS $2.65
  • Analyst Decision
  • SVRN
  • HSCS Strong Buy
  • Analyst Count
  • SVRN 0
  • HSCS 2
  • Target Price
  • SVRN N/A
  • HSCS $10.50
  • AVG Volume (30 Days)
  • SVRN 153.3K
  • HSCS 41.7K
  • Earning Date
  • SVRN 12-19-2025
  • HSCS 12-15-2025
  • Dividend Yield
  • SVRN N/A
  • HSCS N/A
  • EPS Growth
  • SVRN N/A
  • HSCS N/A
  • EPS
  • SVRN N/A
  • HSCS N/A
  • Revenue
  • SVRN $19,435,000.00
  • HSCS $6,250.00
  • Revenue This Year
  • SVRN N/A
  • HSCS N/A
  • Revenue Next Year
  • SVRN N/A
  • HSCS N/A
  • P/E Ratio
  • SVRN N/A
  • HSCS N/A
  • Revenue Growth
  • SVRN N/A
  • HSCS N/A
  • 52 Week Low
  • SVRN $1.07
  • HSCS $2.01
  • 52 Week High
  • SVRN $79.25
  • HSCS $6.47
  • Technical
  • Relative Strength Index (RSI)
  • SVRN N/A
  • HSCS 39.22
  • Support Level
  • SVRN N/A
  • HSCS $2.01
  • Resistance Level
  • SVRN N/A
  • HSCS $2.81
  • Average True Range (ATR)
  • SVRN 0.00
  • HSCS 0.28
  • MACD
  • SVRN 0.00
  • HSCS -0.02
  • Stochastic Oscillator
  • SVRN 0.00
  • HSCS 43.75

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: